Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization - ScienceDirect
Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies | SpringerLink
Supplementary appendix
Confidentiality Notice
Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies | SpringerLink
Frontiers | Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
PDF) Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization
Australian Public Assessment Report for Denosumab
FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment? – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free
Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization - ScienceDirect
Frontiers | Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
Hossam A Saad's research works | Amgen, CA and other places
Frontiers | Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
Clinical and imaging features of melanotic neuro-ectodermal tumor of infancy of the maxillary bone: report of four cases and review of the literature | springermedizin.de
PDF) Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization
Frontiers | Assessment of Strategies for Safe Drug Discontinuation and Transition of Denosumab Treatment in PMO—Insights From a Mechanistic PK/PD Model of Bone Turnover
PDF) Predicting Nonlinear Changes in Bone Mineral Density Over Time Using a Multiscale Systems Pharmacology Model
Osteoporosis Assessment Clinical Tool : Juno EMR Support Portal
Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization - ScienceDirect
Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization - ScienceDirect
Supplementary appendix
Confidentiality Notice
Cureus | Pulmonary Sclerosing Pneumocytoma: An Essential Differential Diagnosis for a Lung Nodule | Article
Confidentiality Notice
Frontiers | Assessment of Strategies for Safe Drug Discontinuation and Transition of Denosumab Treatment in PMO—Insights From a Mechanistic PK/PD Model of Bone Turnover